Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection
- PMID: 11088091
- DOI: 10.1001/archinte.160.21.3286
Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection
Abstract
Background: The intriguing differences in the natural course, transmissibility, and epidemiological characteristics of human immunodeficiency virus type 1 (HIV-1) and HIV-2 are still insufficiently explained. Differences in plasma viral load are an obvious possibility, but this has been difficult to investigate because of the lack of tests for HIV-2 RNA.
Objective: To compare plasma HIV RNA load between individuals infected with HIV-1 and HIV-2 in Guinea-Bissau, a West African country with high prevalence and incidence of HIV-1 and HIV-2 infection.
Methods: A total of 102 participants were recruited from ongoing prospective cohort studies. These included 19 HIV-1 and 29 HIV-2 seroincident cases tested at a median of less than 2 years after seroconversion as well as seroprevalent cases with single (9 HIV-1 cases and 31 HIV-2 cases) or dual (n = 14) infections. Plasma HIV RNA levels were determined by a commercial HIV-1 assay and an experimental HIV-2 assay based on the same principles.
Results: The viral set point, ie, the semi-equilibrium reached after seronconversion, was 28-fold lower in recent HIV-2 seroconverters than in recent HIV-1 seroconverters (median, 2500 and 70,000 RNA copies per milliliter, respectively; P<. 001). This difference appeared to persist to symptomatic stages of the diseases. Dually infected individuals had lower plasma HIV-1 RNA levels than singly infected individuals.
Conclusions: The differences between HIV-1 and HIV-2 infection are likely to be caused by differences in plasma viral set point and load, but the mechanisms through which HIV-2 infection is contained to a higher degree than HIV-1 remain to be identified. Arch Intern Med. 2000;160:3286-3293.
Similar articles
-
HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau.J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):31-8. doi: 10.1097/00042560-199709010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9377122
-
Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.N Engl J Med. 2001 Mar 8;344(10):720-5. doi: 10.1056/NEJM200103083441003. N Engl J Med. 2001. PMID: 11236775
-
Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from guinea-bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa.Virology. 1999 Sep 30;262(2):312-20. doi: 10.1006/viro.1999.9867. Virology. 1999. PMID: 10502510
-
HIV treatment in Guinea-Bissau: room for improvement and time for new treatment options.AIDS Res Ther. 2020 Feb 4;17(1):3. doi: 10.1186/s12981-020-0259-6. AIDS Res Ther. 2020. PMID: 32019545 Free PMC article. Review.
-
Serologic confirmation of HIV infection.Optom Vis Sci. 1995 May;72(5):299-301. doi: 10.1097/00006324-199505000-00004. Optom Vis Sci. 1995. PMID: 7667004 Review.
Cited by
-
High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences.Retrovirology. 2013 May 6;10:50. doi: 10.1186/1742-4690-10-50. Retrovirology. 2013. PMID: 23647667 Free PMC article.
-
Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-Bissau.Epidemiol Infect. 2008 Apr;136(4):551-61. doi: 10.1017/S0950268807008758. Epub 2007 Jun 11. Epidemiol Infect. 2008. PMID: 17559692 Free PMC article.
-
Low Postseroconversion CD4+ T-cell Level Is Associated with Faster Disease Progression and Higher Viral Evolutionary Rate in HIV-2 Infection.mBio. 2019 Jan 8;10(1):e01245-18. doi: 10.1128/mBio.01245-18. mBio. 2019. PMID: 30622192 Free PMC article.
-
Update on human immunodeficiency virus (HIV)-2 infection.Clin Infect Dis. 2011 Mar 15;52(6):780-7. doi: 10.1093/cid/ciq248. Clin Infect Dis. 2011. PMID: 21367732 Free PMC article. Review.
-
Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.J Virol. 2007 Sep;81(17):9061-71. doi: 10.1128/JVI.00117-07. Epub 2007 Jun 20. J Virol. 2007. PMID: 17582003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical